Customize your JAMA Network experience by selecting one or more topics from the list below.
Dai X, Meredith D, Sawey E, Kaul P, Smith SC, Stouffer GA. A Quality Improvement Program for Recognition and Treatment of Inpatient ST-Segment Elevation Myocardial Infarctions. JAMA Cardiol. 2016;1(9):1077–1079. doi:10.1001/jamacardio.2016.3031
Rapid reperfusion with percutaneous coronary intervention or thrombolytic therapy is the standard of care for ST-segment elevation myocardial infarction (STEMI). STEMIs that occur in hospitalized patients have delayed symptom recognition, longer times from electrocardiography (ECG) to first-device activation (FDA), lower rates of percutaneous coronary intervention, and higher mortality rates compared with outpatient STEMIs.1-6
We identified the barriers contributing to these delays and implemented a quality improvement program (QIP) to enhance the response to inpatient STEMIs. Our QIP included the following 4 specific interventions: (1) a hospital-wide education campaign aimed at nurses, medical teams, and allied health care professionals on the recognition of inpatient STEMI and the importance of the timely reperfusion; (2) a requirement that ECG technicians and nurses immediately notify the cardiologist if the automated interpretation of an ECG included ***acute MI***; (3) establishment of an inpatient STEMI protocol and a cardiac response team, modeled on the rapid response team; and (4) monthly review of each inpatient STEMI.
Create a personal account or sign in to: